BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9422098)

  • 1. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1.
    Reis CA; Hassan H; Bennett EP; Clausen H
    Tumour Biol; 1998; 19 Suppl 1():127-33. PubMed ID: 9422098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
    Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
    Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity clusters of MUC1-reactive mouse monoclonal antibodies.
    Hanisch FG
    Tumour Biol; 1998; 19 Suppl 1():111-7. PubMed ID: 9422095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides.
    von Mensdorff-Pouilly S; Petrakou E; Kenemans P; van Uffelen K; Verstraeten AA; Snijdewint FG; van Kamp GJ; Schol DJ; Reis CA; Price MR; Livingston PO; Hilgers J
    Int J Cancer; 2000 Jun; 86(5):702-12. PubMed ID: 10797294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation.
    Karsten U; Diotel C; Klich G; Paulsen H; Goletz S; Müller S; Hanisch FG
    Cancer Res; 1998 Jun; 58(12):2541-9. PubMed ID: 9635576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
    Price MR; Rye PD; Petrakou E; Murray A; Brady K; Imai S; Haga S; Kiyozuka Y; Schol D; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Kenemans P; Blockzjil A; Nilsson K; Nilsson O; Reddish M; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker MB; Hilgers J
    Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epitope recognized by the unique anti-MUC1 monoclonal antibody MY.1E12 involves sialyl alpha 2-3galactosyl beta 1-3N-acetylgalactosaminide linked to a distinct threonine residue in the MUC1 tandem repeat.
    Takeuchi H; Kato K; Denda-Nagai K; Hanisch FG; Clausen H; Irimura T
    J Immunol Methods; 2002 Dec; 270(2):199-209. PubMed ID: 12379325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope characterization of MUC1 antibodies.
    Blockzjil A; Nilsson K; Nilsson O
    Tumour Biol; 1998; 19 Suppl 1():46-56. PubMed ID: 9422088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
    Nishimori I; Perini F; Mountjoy KP; Sanderson SD; Johnson N; Cerny RL; Gross ML; Fontenot JD; Hollingsworth MA
    Cancer Res; 1994 Jul; 54(14):3738-44. PubMed ID: 8033093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope mapping of anti-MUC1 mucin protein core monoclonal antibodies.
    Petrakou E; Murray A; Price MR
    Tumour Biol; 1998; 19 Suppl 1():21-9. PubMed ID: 9422085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope characterization of MUC1 antibodies.
    Imai S; Haga S; Kiyozuka Y
    Tumour Biol; 1998; 19 Suppl 1():30-4. PubMed ID: 9422086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides.
    Liu X; Sejbal J; Kotovych G; Koganty RR; Reddish MA; Jackson L; Gandhi SS; Mendonca AJ; Longenecker BM
    Glycoconj J; 1995 Oct; 12(5):607-17. PubMed ID: 8595249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of acceptor substrate primary amino acid sequence on the activity of human UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase. Studies with the MUC1 tandem repeat.
    Nishimori I; Johnson NR; Sanderson SD; Perini F; Mountjoy K; Cerny RL; Gross ML; Hollingsworth MA
    J Biol Chem; 1994 Jun; 269(23):16123-30. PubMed ID: 8206912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence.
    Schol DJ; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Murakami F; Kenemans P; Hilgers J
    Tumour Biol; 1998; 19 Suppl 1():35-45. PubMed ID: 9422087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase from milk or mammary carcinoma cells.
    Stadie TR; Chai W; Lawson AM; Byfield PG; Hanisch FG
    Eur J Biochem; 1995 Apr; 229(1):140-7. PubMed ID: 7744025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of antibodies with highly glycosylated MUC1 mucins from colon carcinoma cells and bile.
    Sikut R; Sikut A; Zhang K; Baeckström D; Hansson GC
    Tumour Biol; 1998; 19 Suppl 1():122-6. PubMed ID: 9422097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation of the tandem repeat unit of the MUC2 polypeptide leading to the synthesis of the Tn antigen.
    Inoue M; Yamashina I; Nakada H
    Biochem Biophys Res Commun; 1998 Apr; 245(1):23-7. PubMed ID: 9535776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies.
    Spencer DI; Price MR; Tendler SJ; De Matteis CI; Stadie T; Hanisch FG
    Cancer Lett; 1996 Feb; 100(1-2):11-5. PubMed ID: 8620429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.